| Literature DB >> 25821555 |
José Luis Rodríguez-Chávez1, Elvia Coballase-Urrutia2, Antonio Nieto-Camacho1, Guillermo Delgado-Lamas1.
Abstract
It has been suggested that the accumulation of biomolecular damage caused by reactive oxygen species (ROS) contributes to aging. The antioxidant activity is related to the ability of certain compounds to protect against the potentially harmful effect of processes or reactions involving ROS. This ability is associated with the termination of free radical propagation in biological systems. From Heterotheca inuloides various compounds which have shown to possess antioxidant capacity and scavenging ROS. The aim of this study was to determine the antioxidant capacity of additional natural components isolated from H. inuloides and some semisynthetic derivatives, their anti-inflammatory activity and the effect on Caenorhabditis elegans nematode life span. Compounds showed ability to inhibit various biological processes such as lipid peroxidation, scavenge nonbiological important oxidants such as (1)O2, OH(∙), H2O2, and HOCl and scavenge non biological stable free radicals (DPPH). Some cadinane type compounds showed possess antioxidant, ROS scavenging capacity, anti-inflammatory activity, and effect on the C. elegans life span. Flavonoid type compounds increased the life of the nematode and quercetin was identified as the compound with the greatest activity. The modification of chemical structure led to a change in the antioxidant capacity, the anti-inflammatory activity, and the survival of the worm.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25821555 PMCID: PMC4363644 DOI: 10.1155/2015/843237
Source DB: PubMed Journal: Oxid Med Cell Longev ISSN: 1942-0994 Impact factor: 6.543
Figure 1Natural products isolated from H. inuloides flowers and derivatives.
Capacity to inhibit lipid peroxidation and to reduce the DPPH radical.
| Compound | IC50
| |
|---|---|---|
| Lipid peroxidation | Reduction of DPPH | |
|
| 4.72 ± 0.11 | >100 |
|
| 3.09 ± 0.19 | 30.66 ± 8.14 |
|
| nd* | nd |
|
| nd | nd |
|
| 4.30 ± 0.27 | 13.11 ± 1.2 |
|
| 6.16 ± 0.06 | >100 |
|
| nd | nd |
|
| 14.46 ± 0.61 | 6.97 ± 0.14 |
|
| 17.35 ± 1.40 | nd |
|
| nd | — |
|
| 1.82 ± 0.12 | nd |
|
| >100 | nd |
|
| >100 | nd |
|
| >100 | nd |
|
| 3.67 ± 0.43 | — |
|
|
| nd |
|
| 6.78 ± 2.16 | 31.74 ± 1 |
*Not determined: at the concentrations tested the activity of compounds was low.
Scavenging capacity of H. inuloides metabolites on hypochlorous acid, hydroxyl radical, peroxide, superoxide anion, and singlet oxygen (IC50).
| Compound | Scavenging capacity IC50
| ||||
|---|---|---|---|---|---|
| HOCl | OH• | H2O2 | O2 − | 1O2 | |
|
| 69.1 ± 8.8* | 133.4 ± 32.6 | 270 ± 2.7* | 114.6 ± 13.9* | 880.4 ± 55.4* |
|
| 202.3 ± 21.9* | 545.4 ± 23.0* | 422 ± 8.0* | 105 ± 7.2* | 538.9 ± 58.6 |
|
| 203.5 ± 23.9* | 607.9 ± 33.5* | 536 ± 14* | 148 ± 13.0* | 112.4 ± 29.3* |
|
| 68.1 ± 5.77* | 161.2 ± 27.2 | 201 ± 6.7* | 20 ± 0.27* | 209.7 ± 44.5* |
|
| 133.9 ± 9.0* | 187.1 ± 44.6 | 252 ± 6.5* | 70.4 ± 3.3* | 237.8 ± 43.1* |
|
| 60.0 ± 5.2* | 139.5 ± 1.1 | 154 ± 6.3* | 12.2 ± 0.22 | 314.4 ± 15.8 |
|
| 106.1 ± 4.4* | 523.8 ± 20.4* | 322 ± 21.0* | 181.5 ± 29.8* | 697 ± 187.0* |
|
| 110.0 ± 15.8* | 435.78 ± 82.0* | 434.5 ± 23.3* | 244.1 ± 78.0* | 478.6 ± 44.7* |
|
| |||||
| Reference compound | Ascorbic acid | DMTU | Pyruvate | NDGA | GSH |
| 278.6 ± 16.7 | 131.5 ± 3.6 | 32.2 ± 1.7 | 11.6 ± 0.13 | 471 ± 77 | |
Data represent the mean ± SE of the three independent assays. The results were analyzed by ANOVA. The Dunnet's multiple comparison test was used to compare outcomes between experimental and control group. * P < 0.05 versus reference compound.
Figure 2ROS scavenging capacity of H. inuloides metabolites and semisynthetic derivatives. C=NDGA (superoxide); pyruvate (H2O2); DMTU (OH−); GSH (1O2); ascorbic Ac. acid (HOCl). The results were analyzed by ANOVA. The Dunnett's Multiple Comparison test was used to compare outcomes between experimental and control group. * P < 0.05.
Anti-inflammatory activities of additional H. inuloides metabolites.
| Compound | Edema | % |
|---|---|---|
| (mg, average SE) | Inhibition | |
|
| 12.07 | — |
|
| 10.50 ± 0.99 | 5.41 |
|
| 1.85 ± 0.52 | 83.33** |
|
| 5.27 ± 0.70 | 65.73** |
|
| 9.80 ± 0.36 | 7.98 |
|
| 7.30 ± 1.15 | 38.86** |
|
| 7.57 ± 0.45 | 36.63** |
|
| 11.87 ± 0.66 | −11.42 |
|
| 11.07 ± 1.15 | 11.06 |
|
| 13.60 ± 0.70 | −13.90 |
|
| 3.73 ± 1.62 | 66.44** |
|
| 9.07 ± 0.70 | 19.46 |
|
| 13.17 ± 0.51 | 13.57 |
|
| 61.90** |
The data represent the mean of three animals ± the standard error of the mean. All the compounds were tested at 1 μmol/ear doses. The results were analyzed by ANOVA. Student's t-test was used to compare outcomes between experimental and control groups. * P < 0.05 versus reference drug.
Summary of Caenorhabditis elegans life span.
| Treatment | Adult life span, 20°C | ( |
| |
|---|---|---|---|---|
| Mean | CI 95% | (Log-rank) | ||
|
| 1 | 0.171–1.962 | 449 | <0.0001 |
|
| 1 | 0.169–1.964 | 479 | <0.0001 |
|
| 13.661 | 13.13–14.209 | 513 | <0.0001 |
|
| 14.391 | 13.776–15.006 | 557 | 0.1175 |
|
|
| 18.41–19.82 | 444 | <0.0001 |
|
| 16.991 | 16.387–17.596 | 470 | <0.0001 |
|
| 16.583 | 15.926–17.239 | 575 | <0.0001 |
|
| 17.74 | 17.04–18.44 | 466 | <0.0001 |
|
| 11.012 | 10.414–11.609 | 434 | 0.0080 |
|
| 13.424 | 12.845–14.003 | 531 | 0.0001 |
|
| 11.659 | 11.103–12.215 | 499 | 0.0150 |
|
| 13.520 | 12.917–14.123 | 496 | 0.0001 |
|
| 15.216 | 14.478–15.955 | 499 | 0.1751 |
|
| 14.943 | 14.471–15.414 | 1098 | |
Figure 3Lifespan survival curves in the presence H. inuloides metabolites. Labels denote the compound used (100 μM). Curve (a) flavonoids, curves (b), (c), and (d) natural and semisynthetic cadinane type compounds.